|
Originally published In Press as doi:10.1074/jbc.M804395200 on July 19, 2008
J. Biol. Chem., Vol. 283, Issue 38, 25821-25828, September 19, 2008
Asp330 and Tyr331 in the C-terminal Cysteine-rich Region of the Luteinizing Hormone Receptor Are Key Residues in Hormone-induced Receptor Activation*
Martijn Bruysters1,
Miriam Verhoef-Post, and
Axel P. N. Themmen2
From the
Department of Internal Medicine, Erasmus MC, P. O. Box 2040, 3000 CA Rotterdam, The Netherlands
The luteinizing hormone (LH) receptor plays an essential role in male and female gonadal function. Together with the follicle-stimulating hormone (FSH) and thyroid stimulating hormone (TSH) receptors, the LH receptor forms the family of glycoprotein hormone receptors. All glycoprotein hormone receptors share a common modular topography, with an N-terminal extracellular ligand binding domain and a C-terminal seven-transmembrane transduction domain. The ligand binding domain consists of 9 leucine-rich repeats, flanked by N- and C-terminal cysteine-rich regions. Recently, crystal structures have been published of the extracellular domains of the FSH and TSH receptors. However, the C-terminal cysteine-rich region (CCR), also referred to as the "hinge region," was not included in these structures. Both structure and function of the CCR therefore remain unknown. In this study we set out to characterize important domains within the CCR of the LH receptor. First, we mutated all cysteines and combinations of cysteines in the CCR to identify the most probable disulfide bridges. Second, we exchanged large parts of the LH receptor CCR by its FSH receptor counterparts, and characterized the mutant receptors in transiently transfected HEK 293 cells. We zoomed in on important regions by focused exchange and deletion mutagenesis followed by alanine scanning. Mutations in the CCR specifically decreased the potencies of LH and hCG, because the potency of the low molecular weight agonist Org 41841 was unaffected. Using this unbiased approach, we identified Asp330 and Tyr331 as key amino acids in LH/hCG mediated signaling.
Received for publication, June 9, 2008
, and in revised form, July 17, 2008.
* This work was supported, in whole or in part, by National Institutes of Health Grant 5R01DK069711-02 (to A. P. N. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
This article is dedicated to the memory of Yongsheng Li.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3 and supplemental methods.
1 Current address: Dept. of Biological Medicines and Medical Technology, RIVM, P. O. Box 1, 3720 BA Bilthoven, The Netherlands.
2 To whom correspondence should be addressed. Tel.: 31-10-7043577; Fax: 31-10-7035430; E-mail: a.themmen{at}erasmusmc.nl.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Mueller, G. Kleinau, M. W. Szkudlinski, H. Jaeschke, G. Krause, and R. Paschke
The Superagonistic Activity of Bovine Thyroid-stimulating Hormone (TSH) and the Human TR1401 TSH Analog Is Determined by Specific Amino Acids in the Hinge Region of the Human TSH Receptor
J. Biol. Chem.,
June 12, 2009;
284(24):
16317 - 16324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kleinau and G. Krause
Thyrotropin and Homologous Glycoprotein Hormone Receptors: Structural and Functional Aspects of Extracellular Signaling Mechanisms
Endocr. Rev.,
April 1, 2009;
30(2):
133 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Agrawal and R. R. Dighe
Critical Involvement of the Hinge Region of the Follicle-stimulating Hormone Receptor in the Activation of the Receptor
J. Biol. Chem.,
January 30, 2009;
284(5):
2636 - 2647.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|